Germany clears Novartis’ MorphoSys $2.9B deal

The German antitrust agency Federal Cartel Office approved on Tuesday Novartis AG’s acquisition of German-based global biopharmaceutical company MorphoSys AG in a trade agreement worth $2.9 billio…